Clinical observation on treatment of multiple organ dysfunction syndrome with auxiliary treatment of Shennong No.33.
- Author:
Wen-xiu CHANG
1
;
Hong-mei GAO
;
Shu-hua CAO
Author Information
- Publication Type:Clinical Trial
- MeSH: APACHE; Adolescent; Adult; Aged; Anti-Bacterial Agents; therapeutic use; Drug Therapy, Combination; Drugs, Chinese Herbal; therapeutic use; Endotoxins; blood; Female; Humans; Male; Middle Aged; Multiple Organ Failure; drug therapy; Phytotherapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2005;25(3):214-217
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the therapeutic effect of Shennong No. 33 (SN33) in treating multiple organ dysfunction syndrome (MODS) by APACHE II and APACHE II scoring.
METHODSOne hundred and twenty-nine patients of MODS were randomly divided into the treated group (n = 72) and the control group (n = 57), they were treated with comprehensive therapy and to the treated group, SN33 was given additionally. The changes of APACHE II and APACHE III scores and blood endotoxin level were observed at the time points of within 24 hrs after hospitalization, and the 3rd, 5th and 7th day.
RESULTSIn the treated group, 50 patients survived and 22 died, while in the control group, 25 survived and 32 died. The APACHE II and APACHE III scores of the survivors were higher than those of the decedent (P<0.05), which in the treated group was lower than those in the control group (P<0.05). The blood level of endotoxin in the treated group was also lower than that in the control group (P<0.05).
CONCLUSIONSN33 in treating MODS could improve patients' condition, lead to the lowering of APACHE scores. APACHE scoring system could be applied as the criteria for evaluating the condition and prognosis of critical patients, and the APACHE III scoring is more accurate.
